Richard Berman is listed as a director on 15 SEC Form D filings by 2 issuers between Oct 2009 and Feb 2022: LISATA THERAPEUTICS, INC. (Basking Ridge, NJ — biotechnology — 2016; $351.9M reported sold to 142 investors) and Ayala Pharmaceuticals, Inc. (Monmouth Junction, NJ — biotechnology — 2009–2022; $11.1M reported sold to 29 investors).
What this means 2 separate companies raised money with this person listed as director, over about 13 years. Across those companies the filings report $363M sold in total.
Listed alongside James Patton (13 shared filings), Roni A. Appel (13 shared filings), John Rothman (11 shared filings), Thomas McKearn (11 shared filings), Thomas Moore (11 shared filings) and 16 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Richard. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 court case matching the name, 12 bankruptcy cases matching the name listed in Key records below.
What this means 13 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 15 public filings for Richard Berman and found 20 differences, 5 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.